ClinicalTrials.govpublic full text
An Open-Label Study of the Safety and Efficacy of Subcutaneous Recombinant Interferon-Gamma 1b (IFN-Gamma 1b) in Patients With Idiopathic Pulmonary Fibrosis (IPF)
lung disease, pulmonary fibrosis, idiopathic pulmonary fibrosis, ipf, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 876377
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.